Media Mentions

Aslam Rawoof Quoted in Agenda Article on Disclosure Transparency in Corporate Governance

September 19, 2024

Benesch Corporate & Securities Partner Aslam Rawoof was featured in Agenda’s article, “Outspoken’ Director Resignations May Suggest Governance Failures.” Aslam said, speaking generally and not about any specific company or situation, “If I see that a director resigned due to a disagreement, given how extremely rare they are, I would think that something very significant must have happened.”

The article highlights Intel’s broader challenges, including potential activist threats, competition, and the need for greater transparency in director resignation disclosures. Governance professionals warn that public airing of grievances can harm board members’ prospects and expose them to litigation risks while negatively impacting the company’s stock price and reputation. A new study suggests disclosing director resignations could alert investors to systemic issues and improve corporate governance.

To read the full article, click here.

Latest News

Media Mentions 5.29.26

Bloomberg Law Quotes Benesch Partner Margo Wolf O’Donnell on USDA Line Speed Proposal and Worker Safety Risks

Margo Wolf O’Donnell, Co-Chair of Benesch’s Labor & Employment Practice Group, was quoted in Bloomberg Law discussing how the USDA’s proposal to increase meat processing line speeds is raising concerns that faster production could worsen worker safety risks, highlighting tensions between regulatory priorities, industry demands and potential legal challenges.

Media Mentions 5.26.26

Benesch Partner Mark Silberman Quoted in Crain’s Chicago Business on AI-Driven Medicaid Audits and Provider Compliance Risks

Mark Silberman, Vice Chair of Benesch’s Healthcare Practice Group, was quoted in Crain’s Chicago Business article, “The feds’ AI fraud hunt alarms Medicaid providers.” The article examines a new federal effort to use AI to analyze Medicaid audits for fraud, as well as concerns that it could penalize healthcare providers for routine billing errors and create broader financial and operational risks.